Home Open Access News Diseases & Conditions News

Diseases & Conditions News

epidemics

Learning from past epidemics: Can we prepare for the future?

Margaret Heffernan, Author of Uncharted, shares her thoughts about how AI, big data and forecasting might not be the solution to the coronavirus, and how society should really be preparing itself for more inevitable epidemics.
Alzheimer’s disease progression

Graph theory in the study of Alzheimer’s disease progression

María J. Peláez1, Prashant Dogra1, Zhihui Wang1, Vittorio Cristini1 1Mathematics in Medicine Program, Houston Methodist Research Institute, Houston, TX 77030, USA.
chronic inflammatory lung diseases

Soluble circulating cytokine receptors in chronic inflammatory lung diseases

Michael Roth discusses soluble circulating cytokine receptors in chronic inflammatory lung diseases, which he describes as the under-estimated regulators of inflammation and remodelling.
research & innovation in cardiovascular disease

Europe deserves more and better research & innovation in cardiovascular disease

Prof Lina Badimon, Chair, ESC Advocacy Committee 2018-2020 Director, Cardiovascular Program (ICCC) – IR, Hospital de la Santa Crue I Sant Pau, argues that Europe deserves more and better research & innovation in cardiovascular disease.
nocturnal haemoglobinuria

A focus on rare disease: Paroxysmal nocturnal haemoglobinuria (PNH)

Maria Piggin, Chair of PNH Support tells us about the rare disease, paroxysmal nocturnal haemoglobinuria (PNH) and in this area, collaborations for change.
Noonan Syndrome

Leading a normal life with a Noonan Syndrome child: Benji Ballard’s story

Katie Ballard, a trustee of the Noonan Syndrome Association, shares her story of son Benjamin after receiving a life-changing diagnosis of Noonan Syndrome and cardiomyopathy.
Pulmonary rehabilitation

Pulmonary rehabilitation: Changing the lives of patients with lung disease

Jessica Eagelton, co-chair of the Taskforce for lung Health Pulmonary Rehabilitation working group, discusses Pulmonary rehabilitation: a drug-free treatment that is changing the lives of people with lung disease.
COVID-19, coronavirus

European Commission announces €232 million aid package to tackle COVID-19

In a bid to tackle the recent outbreak of COVID-19 the European Commission has announced a new aid package worth €232 million.
Global Food Research

Global Food Research: Will front-of-the-package warning labels change our eating habits?

The Global Food Research Program shares their perspective on targeting ultra-processed foods with front-of-the-package warning labels, which is the only impactful approach.
muscle-wasting conditions research

The 2010s: Advances witnessed in muscle-wasting conditions research

Kate Adcock, Director of Research and Innovation, Muscular Dystrophy UK, charts the advances over the past decade in muscle-wasting conditions research.
infectious diseases in Africa

Assessment and surveillance to mitigate infectious diseases in Africa

Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group, gives a call to action when it comes to assessment and surveillance to mitigate the impact of infectious diseases in Africa.
idiopathic pulmonary fibrosis

Lung disease: A focus on idiopathic pulmonary fibrosis

Stephen C Clark, from Newcastle upon Tyne Hospitals NHS Foundation Trust and University of Northumbria in the UK explains idiopathic pulmonary fibrosis, a type of lung disease.
coronavirus vaccine

Government pledges £20 million to develop new coronavirus vaccine

The Government has today pledged £20 million to develop a new coronavirus vaccine following concerns over the ongoing outbreak in China.
cases of coronavirus confirmed

Multiple cases of coronavirus confirmed in the UK

Chief Medical Officer, Professor Chris Whitty has announced that two cases of coronavirus have been confirmed in England.
traumatic brain injury, disease control

Controlling and preventing diseases: A focus on traumatic brain injury

The work of the Centers for Disease Control and Prevention, within the U.S. Department of Health & Human Services is examined here, with a special focus on traumatic brain injury.
inflammatory lung diseases

Fine dust air pollution (PM2.5) as a cause of chronic inflammatory lung diseases?

Michael Roth, Research Group Leader at University Hospital Basel asks if fine dust air pollution (PM2.5) is a cause of chronic inflammatory lung diseases and provides a most engaging response.

Environmental exposures during early life influence adult disease risk

Carolyn R. Klocke and Pamela J. Lein discuss how an individual’s experiences during early life can influence their risk for disease as an adult.
Living with Chronic Obstructive Pulmonary Diseases

Living with Chronic Obstructive Pulmonary Diseases (COPD)

More can be done at the local, national and EU level to improve COPD diagnosis, support smoking cessation and advance work and living conditions for people living with COPD.
cause of disability and premature death

Cardiovascular disease: A leading cause of disability and premature death

Dr Tejas Patel, a world-renowned interventional cardiologist and endovascular therapist, highlights cardiovascular disease, a leading cause of disability and premature death around the world.
genetic brain disease, Hereditary spastic paraplegias

Researchers discover new genetic brain disease

Manchester researchers have contributed towards the discovery of a genetic brain disease which can cause paraplegia and epilepsy in sufferers.

Follow Open Access Government

Latest Special Reports

Latest Health eBooks